The Discounted Cash Flow (DCF) valuation of Sunshine Biopharma Inc (SBFM) is (6,487.45) USD. With the latest stock price at 1.50 USD, the upside of Sunshine Biopharma Inc based on DCF is -434042.8%.
Based on the latest price of 1.50 USD and our DCF valuation, Sunshine Biopharma Inc (SBFM) is a sell. selling SBFM stocks now will result in a potential gain of 434042.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.5% - 9.3% | 8.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (11,183.27) - (4,585.50) | (6,487.45) |
| Upside | -748144.7% - -306822.1% | -434042.8% |